Skip to main content

Kurma Partners — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

84
Companies
$1.8B
Total invested
$26.0M
Avg. check
29
Industries
Biotechnology 13Health Care 12Pharmaceutical 7Medical 5Genetics 3Medical Device 3+23 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 2548 of 84
Avidicure
April 2025

Avidicure is pioneering an entirely new dual agonistic, multifunctional and avidity engineered antibody modality.

Oegstgeest$50.0M Seed
Hopia
January 2025

Optimized resource planning solution for healthcare institutions

Health Care · Paris$3.7M Seed
PanTera
September 2024

PanTera produces actinium-225 for personalized cancer treatment and radiopharmaceuticals.

Health Care · Mol$110.3M Series A
SciRhom
July 2024

SciRhom is a biotech enterprise that translate advanced scientific findings into game-changing therapies for autoimmune diseases.

Biotechnology · Martinsried$68.1M Series A
Stilla Technologies
February 2024

Stilla Technologies is a Paris-based european biotechnology company.

Biotechnology · Villejuif$26.5M Series C
BioSerenity
November 2023

BioSerenity provides remote monitoring and diagnostic software for healthcare sectors.

Health Care · Paris$25.7M Venture - Series Unknown
Shorla Pharma
October 2023

Shorla Pharma is an Irish specialty pharmaceutical company.

Biotechnology · Clonmel$35.0M Series B
Corteria Pharmaceuticals
September 2023

Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.

Biotechnology · Paris$69.5M Series A
Xeltis
August 2023

Xeltis is a clinical-stage medtech company with the world's most advanced polymer-based platform of restorative cardiovascular devices.

Health Care · Eindhoven$13.6M Series D
Kiro
March 2023

Kiro is an IT company that offers artificial intelligence, ergonomic design, and software development solutions for medical biology.

Artificial Intelligence (AI) · Paris$15.0M Series A
Ganymed Robotics
January 2023

Ganymed Robotics develops smart robots for orthopedic surgery.

Robotics · Paris$15.9M Series B
Coave Therapeutics
January 2025

Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.

Biotechnology · Paris$32.9M Series A
Alveus Therapeutics
January 2026

Alveus Therapeutics is a clinical-stage biotech company developing therapies for obesity and metabolic diseases.

Biotechnology · Philadelphia$197.0M Series A
NaoX Technologies
January 2022

NaoX Technologies develops wireless headphones that listen to brain vibrations.

Fitness · Palaiseau$4.8M Seed
Omnidoc
December 2024

Omnidoc is a tele-expertise platform for healthcare professionals to exchange medical opinions.

Collaboration · Paris$6.3M Venture - Series Unknown
Meiogenix
December 2024

Meiogenix is a biotechnology company that develops breeding technologies.

Biotechnology · ParisSeries A
PathoQuest
November 2021

PathoQuest is a biotech company developing NGS-based metagenomic tests for exhaustive identification of pathogens.

Biotechnology · Paris$17.4M Series B
Raidium
November 2024

Radiology augmented GPT to tackle the complexity of precision medicine

Artificial Intelligence (AI) · Paris$16.9M Seed
DAMAE Medical
November 2025

DAMAE Medical develops an innovative imaging process for quick and non-invasive skin cancer detection.

Biotechnology · Paris$17.4M Series B
Charles.co
March 2026

Charles helps men regain control over their daily health concerns by starting with their personal health.

Fitness · Paris$297K Secondary Market
Step Pharma
February 2026

Step Pharma is a biotechnology company.

Biotechnology · Paris$2.9M Grant
Laigo Bio
December 2025

Laigo Bio uses E3 ligase internalization to precisely degrade membrane proteins linked to autoimmune and inflammatory disorders.

Biotechnology · Utrecht$13.4M Seed
Adcytherix
October 2025

Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC).

Biotechnology · Marseille$122.8M Series A
Minoryx Therapeutics
July 2025

Minoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases.

Biotechnology · Barcelona$31.5M Grant

Where Kurma Partners invests

Biotechnology13
Health Care12
Pharmaceutical7
Medical5
Genetics3
Medical Device3

About Kurma Partners's portfolio

How many companies has Kurma Partners invested in?

Kurma Partners has invested in 84 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Kurma Partners invest in?

Kurma Partners's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Medical, Genetics. The firm invests across 29 different industry categories.

What is Kurma Partners's largest investment?

Among tracked funding rounds, Alveus Therapeutics received $197.0M in a Series A round. Kurma Partners's total known invested capital is $1.8B.

What is the average investment size for Kurma Partners?

Kurma Partners's average investment size is $26.0M across its portfolio of 84 companies.

What are Kurma Partners's most recent investments?

Recent Kurma Partners portfolio additions include Avidicure, Hopia, PanTera, SciRhom, Stilla Technologies. These companies were founded in 2020 or later.

Reach the founders behind these 84 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →